Latest filing published 19 Aug 2024 for Seres Therapeutics, Inc..
Insider track record
No signal scores available.
David S. Ege: trading record in brief
David S. Ege discloses dealings in Seres Therapeutics, Inc. to SEC (Form 4). The record holds 13 filings, for trades running from 5 July 2022 to 16 August 2024.
No open-market purchase appears, only 6 sales worth €85k. The rest of the record consists of 3 share grants and 4 option exercises. In 2024 alone, the filings show no purchases and 3 sales.
The latest filing, published on 19 August 2024, reports an open-market sale of €864 in Seres Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David S. Ege
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,969 sharesCommon StockSEC:0000950170-24-098699:0
- 2,968 sharesCommon StockSEC:0000950170-24-062056:0
- 11,875 sharesCommon StockSEC:0000950170-24-016688:0
- 11,361 shares0Common StockSEC:0000899243-23-020075:0
- 20,000 shares0Common stockSEC:0000899243-23-011945:0
- 20,000 shares0Common stockSEC:0000899243-22-034598:0
- 31,746 shares@ US$3.15100.0% of flowCOMMON STOCKSEC:0000899243-22-025514:0
7 of 7 declarations
